To provide for a limitation on availability of funds for District of Columbia, Federal Payment for Testing and Treatment of HIV/AIDS for fiscal year 2024.
Active· Referred to the House Committee on Oversight and Accountability.
Introduced
Mar 29, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Mar 29, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Executive Summary
This bill limits FY2024 funding for testing and treatment of HIV/AIDS in the District of Columbia.
Action Timeline
3
MAR 29, 2023•IntroReferral
Introduced in House
MAR 29, 2023•IntroReferral
Introduced in House
MAR 29, 2023•IntroReferral
Referred to the House Committee on Oversight and Accountability.